It has been 20 years since Wei Wu in M.G. Rosenfeld’s Research Unit first identified inactivating mutations of the PROP1 gene in humans with combined pituitary hormone deficiency (CPHD) (1). The gene discussed is PROP1; the disease is hypopituitarism.